Recently, the first trial date was set in a group of over 8,000 personal injury and product liability lawsuits pending against Pfizer, Inc., claiming its menopause drug Prempro is a defective and dangerous product because it has been linked to breast cancer. The drug was used to treat symptoms such as hot flashes and mood swings. More than six million woman took the drug; however, in 2002 a study revealed a link to breast cancer. Thousands of lawsuits were subsequently filed all across the country, resulting in consolidation for pretrial purposes in an Arkansas federal court. Some of those cases are now being sent back to their original filing court so that trial dates can be set. The first case to be set for trial is an action brought by Karen Zahn against Pfizer’s Wyeth division, which is now back pending before a judge in Galveston, Texas. The trial is scheduled to begin in May, 2011.